Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Neovasc Inc. NVCN

Healthcare Medical Instruments & Supplies
Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter... see more

Recent & Breaking News (NDAQ:NVCN)

Neovasc Reducer Featured in Live Case at Berlin Symposium

PR Newswire January 18, 2018

Neovasc Reports Tiara's Clinical Case Load Accelerating

PR Newswire January 8, 2018

Neovasc Receives NASDAQ Notification Regarding Minimum Bid Requirements

Canada NewsWire January 2, 2018

Neovasc Reducer Featured in Live Case at ICI 2017

PR Newswire December 6, 2017

Neovasc to Present at the Piper Jaffray 29th Annual Healthcare Conference

Canada NewsWire November 27, 2017

Neovasc Closes Offering of Units Consisting of Common Shares and Warrants and Concurrent Private Placement of Notes and Warrants

Canada NewsWire November 17, 2017

Neovasc Announces Results for the Third Quarter of 2017

Canada NewsWire November 14, 2017

Neovasc to Host Third Quarter 2017 Conference Call

Canada NewsWire November 10, 2017

Neovasc Announces US$65 Million Underwritten Offering of Units Consisting of Common Shares and Warrants To Purchase Common Shares and Concurrent Private Placement of Notes and Warrants

PR Newswire November 10, 2017

Neovasc Receives FDA Approval to Initiate Pivotal Reducer Trial

Canada NewsWire November 6, 2017

Neovasc Provides Litigation Update

Canada NewsWire November 3, 2017

Neovasc Provides Tiara™ Clinical Update

Canada NewsWire September 12, 2017

Neovasc's Reducer System Reviewed in European Heart Journal

PR Newswire September 5, 2017

IIROC Trade Resumption - NVCN

Canada NewsWire September 1, 2017

IIROC Trade Resumption - Neovasc Inc.

Newsfile September 1, 2017

Decision from Appeals Court upholds lower court decisions but denies injunction

Canada NewsWire September 1, 2017

IIROC Trading Halt - NVCN

Canada NewsWire September 1, 2017

IIROC Trade Halt - Neovasc Inc.

Newsfile September 1, 2017

Neovasc to Host Second Quarter 2017 Conference Call

Canada NewsWire August 3, 2017

Medical Equipment Stock Performance Review -- Amedica, Neovasc, Accuray, and NuVasive

PR Newswire July 21, 2017